GILD

Gilead Sciences, Inc. News Headlines

$101.38
*  
1.96
1.9%
Get GILD Alerts
*Delayed - data as of Apr. 17, 2015  -  Find a broker to begin trading GILD now
Exchange: NASDAQ
Industry: Health Care
Community Rating:
 
 
Symbol List Views
FlashQuotes InfoQuotes
Stock Details
Summary Quote Real-Time Quote After Hours Quote Pre-market Quote Historical Quote Option Chain
CHARTS
Basic Chart Interactive Chart
COMPANY NEWS
Company Headlines Press Releases Market Stream
STOCK ANALYSIS
Analyst Research Guru Analysis Stock Report Competitors Stock Consultant Stock Comparison
FUNDAMENTALS
Call Transcripts Annual Report Income Statement Revenue/EPS SEC Filings Short Interest Dividend History
HOLDINGS
Ownership Summary Institutional Holdings Insiders
(SEC Form 4)
 Save Stocks
Viewing
Filtered By
Ordered By

Why Merck's Victory Is of Little Concern to Gilead
4/10/2015 10:00:00 AM - Investopedia




A New Fifty-Year-Old Hepatitis C Drug
4/9/2015 5:06:00 PM - Seeking Alpha










Gilead's Little Tweak Could Produce Big Revenue
4/8/2015 3:58:00 PM - Investopedia




Chasing - And Surviving - Today's Income Storm
4/8/2015 1:19:00 PM - Seeking Alpha










Gilead's CEO John Martin: Worth The Money?
4/6/2015 4:43:00 PM - Seeking Alpha




Gilead: Price Dip Offers A Strong Buying Opportunity
4/6/2015 4:03:00 PM - Seeking Alpha